DeepThink PTB

Published by: Deepthink Health
Downloads
Revenue

Description

DeepThink Health Precision Tumor Board ™
Advancing medicine with precision intelligence ™

DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Just as in the desktop Precision Tumor Board application, in our mobile app we’ve integrated and processed a cancer patient’s molecular/genomic tumor report enabling Molecular Tumor Board and Standard Tumor Board to quickly interpret the complex data for oncologists urgently needing to prescribe the right therapies for their cancer patients. Tumor Board members can:
• Quickly see FDA approved therapies with predictive responses for the patient’s specific tumor type and genetic characteristics
• Easily select among targeted therapies based on biomarkers or suggest therapies to enhance the molecular report interpretation
• See clinical trials already screened for the patient case in context
• Collaborate with other Molecular Tumor Board members to quickly and timely provide a succinct report to the treating oncologist
• Schedule and hold virtual tumor board meeting
• No private health information is stored or relayed in the application, DeepThink Health products are HIPAA compliant.

About DeepThink Health
DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Our team has extensive experience and success in leading Healthcare IT companies serving providers, payers and pharmacies. Our Precision Analytics and Precision Intelligence solutions have been successfully implemented at large Healthcare IDNs where the combined genomic, clinical and outcome data were analyzed using DeepThink Artificial Intelligence tools to advance precision medicine and enable novel discoveries.
Hide Show More...

Screenshots

DeepThink PTB FAQ

  • Is DeepThink PTB free?

    Yes, DeepThink PTB is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is DeepThink PTB legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does DeepThink PTB cost?

    DeepThink PTB is free.

  • What is DeepThink PTB revenue?

    To get estimated revenue of DeepThink PTB app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Nigeria yet.
Ratings History

DeepThink PTB Reviews

No Reviews in Nigeria
App doesn't have any reviews in Nigeria yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

DeepThink PTB Competitors

Name
ASTCT Practice Guidelines
BUMP by 4YouandMe
Skin Therapy Letter
Neuro-oncology: WTD
What's the data?
Immuno-Oncology
from @ Point of Care™
Skin Cancer Manager
Track Your Medical Journey
Washington Manual of Oncology
Cancer Tx in Outline Format
Philips IntelliSite Pathology
Medeligo
Luigi
Pathological Image Retrieval

DeepThink PTB Installs

Last 30 days

DeepThink PTB Revenue

Last 30 days

DeepThink PTB Revenue and Downloads

Gain valuable insights into DeepThink PTB performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
Deepthink Health
Languages
English
Recent release
2.02 (2 years ago )
Released on
Nov 27, 2019 (5 years ago )
Last Updated
1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.